On 1 January 2020, Russia will introduce a new, compulsory system for tracking pharmaceuticals from manufacturer to end user. This new legislation should be considered alongside wider global efforts to enhance quality control and put in place protection against fake and counterfeit medicines. Christoph Krähenbühl at Excellis Europe outlines the challenges that the new Russian traceability regulations present to the pharma industry.